ClinicalTrials.Veeva

Menu

Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

F

Far Eastern Memorial Hospital

Status

Completed

Conditions

Overactive Bladder Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT01819168
102026-E

Details and patient eligibility

About

The aim of this retrospective study is to analyze if nighttime antimuscarincs may be more effective in treating patients with nocturia.

Enrollment

38 patients

Sex

Female

Ages

20 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who underwent tolterodine SR treatment once per day for 12 weeks in Department of Obstetrics & Gynecology in National Taiwan University Hospital and Far Eastern Memorial Hospital

Exclusion criteria

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems